EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study

Junfeng Qi, Longzhu Xiong, Chuansha Wu, Xiaojie Sun, Junlin Li, Likun Ren, Chaoliang Yi, Yuqin Shi, Ling Zhang, Xiongfei Pan iD, Ting Zhou, Shuzhen Zhu

Obesity · 2026

DOI: 10.1002/oby.70269 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Obesity, 2026. Verfasst von Junfeng Qi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chronic and Non-Communicable Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, C…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Body Mass Index, Weight Loss, Obesity. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Central Government Transfer Payment for Major Local Public Health Projects: Early Screening and Intervention for High-Risk Populations with Cardiovascular Dise…, Health Commission of Hubei Province, Hubei Provincial Advantaged Characteristic Disciplines (Groups) Project of Wuhan University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to explore personalized weight‐loss targets for metabolic syndrome (MetS) reversal by introducing the BMI‐normalization achievement rate (BMI‐NAR), a novel baseline‐BMI‐scaled metric.

Methods

In a longitudinal cohort of 7340 adults with overweight/obesity and MetS from the ChinaHEART project, BMI‐NAR was defined as the percentage of progress toward a normal BMI (< 24 kg/m 2 ). Logistic regression and restricted cubic splines assessed the dose–response relationship between BMI‐NAR and MetS reversal.

Results

Each 50% increase in BMI‐NAR was significantly associated with MetS reversal (overall: OR = 1.10, 95% CI: 1.07–1.12; overweight: OR = 1.08, 95% CI: 1.06–1.11; obesity: OR = 2.36, 95% CI: 2.00–2.80). The probability of reversal increased steeply beyond exploratory minimum effective thresholds (37% BMI‐NAR for overall; 53% for overweight; 22% for obesity), with benefits observed up to ~165% in the total population, beyond which data were sparse. No clear upper plateau was identified in populations with overweight and obesity. These exploratory thresholds translate into personalized weight‐loss targets: a minimum reduction of 2%–8% for typical overweight (baseline BMI 25–27.99 kg/m 2 ) and 3%–9% for obesity.

Conclusions

MetS reversal does not require full BMI normalization. BMI‐NAR provides a hypothesis‐generating, quantifiable framework for exploring personalized minimum effective weight‐loss goals in this high‐risk population. However, external validation is required before clinical application. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeBody Mass IndexWeight LossObesityHumansFemaleMiddle AgedLongitudinal StudiesMaleOverweightAdultPrecision MedicineChinaCohort StudiesLogistic Models

Stichwörter der Autor:innen

BMI normalizationmetabolic syndrome reversalobesityoverweightweight‐loss

Autor:innen und Institutionen

  • Institute of Chronic and Non-Communicable Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China.
  • Environmental Toxicology Laboratory, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Healthy Hubei Development and Social Progress Research Center of the Key Research Base of Humanities and Social Sciences in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan, Hub…

ORCID-Profile: Xiongfei Pan

Förderung

  • Central Government Transfer Payment for Major Local Public Health Projects: Early Screening and Intervention for High-Risk Populations with Cardiovascular Dise…
  • Health Commission of Hubei Province
  • Hubei Provincial Advantaged Characteristic Disciplines (Groups) Project of Wuhan University of Science and Technology

Zitieren

APA

Qi, J., Xiong, L., Wu, C., Sun, X., Li, J., Ren, L., Yi, C., Shi, Y., Zhang, L., Pan, X., Zhou, T., & Zhu, S. (2026). Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study. Obesity. https://doi.org/10.1002/oby.70269

Vancouver

Qi J, Xiong L, Wu C, Sun X, Li J, Ren L, et al. Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study. Obesity. 2026. doi:10.1002/oby.70269

BibTeX
@article{Qi2026,
  author = {Qi, Junfeng and Xiong, Longzhu and Wu, Chuansha and Sun, Xiaojie and Li, Junlin and Ren, Likun and Yi, Chaoliang and Shi, Yuqin and Zhang, Ling and Pan, Xiongfei and Zhou, Ting and Zhu, Shuzhen},
  title = {Personalized Weight‐Loss Targets for Metabolic Syndrome Reversal: A BMI ‐Normalization Achievement Rate‐Based Cohort Study},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70269}
}
Kostenlos starten →